Our retina experience will redefine your retina experience
ABOUT OCULAR THERAPEUTIX
Ocular is committed to redefining the retina experience across drug development, treatment, and outcomes
“We have sharpened our focus on a single, bold mission – to redefine the retina experience – starting with wet age-related macular degeneration (AMD) as our top priority. There is a significant opportunity to also expand into non-proliferative diabetic retinopathy (NPDR) and diabetic macular edema (DME), where millions remain untreated.”
Pravin Dugel, MD,
Executive Chairman, President, and CEO
Redefining treatment
By helping to reduce the therapeutic burden, so more patients can stay on treatment
Redefining development
By bringing unmatched retinal expertise to clinical trial design and execution
Redefining outcomes
In the hopes of preserving vision for the long-term
MEET THE TEAM
Our team has unmatched expertise and an impressive track record of innovation in retinal disease
Read our
latest news
Learn about
life at Ocular
Explore our
pipeline